Participant code-gender | Age range | Neurological level of injury | AIS | Cause of injury | Time since injury (yr) | Anti-spastic medication |
---|---|---|---|---|---|---|
P1 | 2 | T3 | B | MVA | 4.2 | Baclofen |
P2 | 1 | C7 | C | MVA | 5.7 | Baclofen, Tizanidine, Oxybutynin |
P3 | 1 | C6 | C | MVA | 2.5 | Baclofen, Oxybutynin |
P4 | 3 | T6 | A! | Crush injury | 24.2 | Baclofen, Diazepam, Oxybutynin |
P5 | 2 | T4 | A! | Sports | 16.2 | Oxybutynin |
P6 | 2 | T3 | A | MVA | 4.3 | Oxybutynin |
P7 | 1 | T7 | A | MVA | 2.4 | Baclofen, Oxybutinin |
P8 | 2 | T9 | A | Fall | 1.3 | Oxybutynin |
P9 | 1 | T10 | B! | MVA | 2.0 | Baclofen |
P10 | 2 | T4â–² | Câ–² | MVA | 4.4 | Baclofen, Oxybutinin |
P11 | 3 | C6 | D! | MVA | 18.7 | Baclofen |
P12 | 1 | T7 | A! | MVA | 1.6 | Baclofen |
Meana (SD) | 37.5 (13.7) | Â | Â | Â | 7.6 (8.1) | Â |